Gene therapies been re-branded 'advanced therapies'—the feeding frenzy continues
Even FDAs top vaccine guy, Peter Marks, is in on it!
[Note: this is a recycle from Jun 21, 2024]
Keep getting this advanced therapy conference in my mailbox
Every few weeks, I get an email from Terrapinn, asking me to buy a ticket for their 2024 conference on advanced therapies. The speaker list is below:
Advanced Therapies 2024, 19-20th March, ExCeL London
[Note: the link now refers to the 2025 conference and Peter Marks below is not featured. However, I’m sure the conference producers will confirm his attendance from 2020 - 2024]
Scroll down to speakers with the name beginning with ‘M’, and you will see Peter Marks M.D., PhD., Director - Center for Biologics Evaluation and Research (CBER) .
Marks is the person with delegated authority to evaluate and research applications to market new biologics drugs, eg vaccines.
Could this just be a teeny weeny conflict of interest?
Not at all, it’s a massive one!!!
It is also unprecedented for someone in his position to do anything other than fly-in for a Keynote Address, then fly out again. Hob nobbing …